EUROCAT Working Group members: Dr Lenore Abramsky, North Thames (West) Congenital Malformation Register, UK; Dr Marie-Claude Addor, Division de Genetique Medicale, Lausanne, Switzerland; Dr Nicola Armstrong, EUROCAT Central Registry, UK; Dr Neus Baena, El Valles, Spain; Dr Marian Bakker, Groningen, Netherlands; Dr Ingeborg Barisic, Zagreb, Croatia; Dr Sebastiano Bianca, Sicily, Italy; Dr Patricia Boyd, OXCAR, UK; Dr Catherine De Vigan, Paris, France; Dr Elizabeth Draper, Trent, UK; Dr Ester Garne, Odense, Denmark; Dr Miriam Gatt, Malta, Malta; Dr Blanca Gener, Registry of Congenital Anomalies of the Basque Country (RACAV), Spain; Dr Martin Haeusler, Styria, Austria; Dr Lorentz Irgens, Norway; Hilary Jordan, Glasgow, UK; Maria Loane, EUROCAT Central Registry, UK; Dr M.T. O'Mahony, Cork & Kerry Registry, Ireland; Dr Maria-Luisa Martínez-Frías and Dr Eva Berjemo, ECEMC, Spain; Dr Bob Mc Donnel, Dublin, Ireland; Dr Vera Nelen, Antwerp, Belgium; Dr Amanda Neville, Dr Olga Clabrese, Dr Francesca Rivieri, IMER Registry, Italy; Dr Anna Pierini and Dr Fabrizio Bianchi, Tuscany, Italy; Dr Isolina Riaño Galán, Asturias, Spain; Dr Annukka Ritvanen, The Finnish Register of Congenital Malformations, STAKES, Finland; Dr Elisabeth Robert-Gnansia, Central East France, France; Dr Claude Stoll, Strasbourg, France; Dr Maria Soares, Southern Portugal, Portugal; Dr Romano Tenconi, North East Italy, Italy; Dr Diana Wellesley, Wessex, UK; Dr Awi Wiesel, Mainz, Germany.
The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study†
Article first published online: 7 JUN 2006
Copyright © 2006 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 15, Issue 9, pages 675–682, September 2006
How to Cite
Meijer, W. M., Cornel, M. C., Dolk, H., de Walle, H. E. K., Armstrong, N. C., de Jong-van den Berg, L. T. W. and EUROCAT Working Group (2006), The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study. Pharmacoepidem. Drug Safe., 15: 675–682. doi: 10.1002/pds.1265
No conflict of interest was declared.
- Issue published online: 26 AUG 2006
- Article first published online: 7 JUN 2006
- Manuscript Accepted: 29 MAR 2006
- Manuscript Revised: 27 MAR 2006
- Manuscript Received: 31 AUG 2005
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.